Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-004557-15Phase 4Completed
Phase 4, single-arm trial of Mirfulan, sponsored by Recordati SpA. Primary endpoint: Change in transepidermal water loss from post-blister induction to day 10. Started Sep 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-004557-15.